Most Read Articles
Pearl Toh, 31 Dec 2019
Adding the neuraminidase inhibitor oseltamivir to usual care speeds up recovery from influenza-like illness by a day compared with usual care alone, with even greater benefits seen in older, sicker patients with comorbidities, according to the ALIC4E study.
23 Dec 2019
At a Menarini-sponsored symposium held during the Asian Pacific Society Congress, renowned cardiologist Prof John Camm provided the latest evidence for chronic stable angina with or without concomitant diseases, with a special focus on the antianginal agent ranolazine and combination therapies. The event was chaired and moderated by Dr Dante Morales from the University of the Philippines College of Medicine.
5 days ago
Testosterone treatment may slightly improve sexual functioning and quality of life in men without underlying organic causes of hypogonadism, but it offers little to no benefit for other common symptoms of ageing, according to a study. In addition, long-term efficacy and safety of this therapy remain unknown.
6 days ago
Prevention of glucocorticoid-induced osteoporosis (GIOP) and postmenopausal osteoporosis (PMOP) remains inadequate in patients with rheumatoid arthritis (RA), as shown in a study that evaluated the implementation of the 2003 and 2014 French guidelines on the prevention and treatment of GIOP and the 2012 update of the French guidelines for the treatment of PMOP.

Pharmacist interventions prevent drug-related problems in cancer chemotherapy

15 Aug 2019

The introduction of clinical pharmacy services has led to improved therapy effectiveness and fewer adverse effects and unclear/compliant problems in cancer chemotherapy, a study has shown. Moreover, oncologists and patients highly acknowledge these pharmacist interventions, indicating a need to implement clinical pharmacy services in alternative hospitals.

A total of 102 patients treated with at least two cycles of any cancer type and stage were included in the analysis. Of these, 55 (53.9 percent) had 251 drug-related problems, which primarily involved antihypertensive (31.6 percent), antidiabetic (17.8 percent) and herbal agents (31.6 percent). The most common type of drug-related problems was treatment effectiveness (50.2 percent), followed by treatment safety (29.1 percent).

All 211 pharmacist interventions (110 percent) were accepted and deemed clinically relevant. At the prescriber level, the most common type of intervention was prescriber informed only. Of the identified drug-related problems, 86.4 percent were solved, 9.8 percent were partially solved, and 2.3 percent were unsolved.

“Clinical pharmacists have important roles in implementing scientifically valid knowledge and advice on safe, reasonable use of pharmaceuticals,” the authors said.

This prospective interventional study conducted from November 2017 to March 2018 used the Pharmaceutical Care Network Europe drug-related problem classification tool v8.01 to classify drug-related problems. The main outcome measure was the proposed interventions, which sought to identify drug-related problems, the role of the pharmacists in the resolution and the rate of acceptance of these recommendations by physicians.

“Clinical pharmacy services were introduced and evaluated in oncology clinic in a tertiary university hospital,” the authors said.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Pearl Toh, 31 Dec 2019
Adding the neuraminidase inhibitor oseltamivir to usual care speeds up recovery from influenza-like illness by a day compared with usual care alone, with even greater benefits seen in older, sicker patients with comorbidities, according to the ALIC4E study.
23 Dec 2019
At a Menarini-sponsored symposium held during the Asian Pacific Society Congress, renowned cardiologist Prof John Camm provided the latest evidence for chronic stable angina with or without concomitant diseases, with a special focus on the antianginal agent ranolazine and combination therapies. The event was chaired and moderated by Dr Dante Morales from the University of the Philippines College of Medicine.
5 days ago
Testosterone treatment may slightly improve sexual functioning and quality of life in men without underlying organic causes of hypogonadism, but it offers little to no benefit for other common symptoms of ageing, according to a study. In addition, long-term efficacy and safety of this therapy remain unknown.
6 days ago
Prevention of glucocorticoid-induced osteoporosis (GIOP) and postmenopausal osteoporosis (PMOP) remains inadequate in patients with rheumatoid arthritis (RA), as shown in a study that evaluated the implementation of the 2003 and 2014 French guidelines on the prevention and treatment of GIOP and the 2012 update of the French guidelines for the treatment of PMOP.